The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
To provide an IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant or cellular therapies for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.
To provide a consent mechanism for the retrospective study of cellular products, when available, if there is a specific question to be addressed.
Age
18–120
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant
You may not be if
Participation in any other treatment research protocol